Contribution of Chronic Myeloid Leukaemia (CML) as a Disease Model to Define and Study Clonal Heterogeneity - Role of intra-Clonal HEterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias Accéder directement au contenu
Chapitre D'ouvrage Année : 2019
Fichier non déposé

Dates et versions

hal-02301455 , version 1 (30-09-2019)

Identifiants

Citer

Marc Berger, Céline Bourgne. Contribution of Chronic Myeloid Leukaemia (CML) as a Disease Model to Define and Study Clonal Heterogeneity. Advances in experimental médicine and biology, 1139, pp.171-185, 2019, ⟨10.1007/978-3-030-14366-4_10⟩. ⟨hal-02301455⟩
31 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More